Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Ira Smalberg

Diagnostic Radiology Santa Monica, CA Medical Doctor

NPI 1952356255 CMS profile 959975

2202 Wilshire Blvd, Santa Monica, CA 90403

Open in the dashboard

General payments

$451,358

361 records reported · program years 2019–2024

Research payments

$1,539,690

Paid to them · 87 records reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$503,733 paid to institutions, not to them · program years 2019–2025

Through program year 2024, Ira Smalberg of Santa Monica, CA is reported in the CMS Open Payments database as having received $451,358 across 361 general payments and $1,539,690 in research payments paid to them. Separately, studies naming them as principal investigator received $503,733 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $450 2
2023 General $102,915 28
2023 Research $292,468 14
2022 General $101,458 15
2022 Research $209,708 30
2021 General $54,693 81
2021 Research $250,315 15
2020 General $83,647 130
2020 Research $365,788 13
2019 General $108,196 105
2019 Research $421,411 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ira Smalberg
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Ira Smalberg were reported at $0. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Ira Smalberg Diagnostic Radiology median Middle half National median
2019 $108,196 $108 $29–$318 $163
2020 $83,647 $65 $21–$252 $114
2021 $54,693 $92 $24–$292 $132
2022 $101,458 $104 $29–$294 $149
2023 $102,915 $110 $29–$337 $160
2024 $450 $113 $30–$356 $164
2025 $0 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Merck Sharp & Dohme Corporation $238,121 304 payments
  2. AstraZeneca UK Limited $193,125 24 payments
  3. Boehringer Ingelheim International GmbH $11,248 19 payments
  4. Seattle Genetics, Inc. $5,380 4 payments
  5. Pfizer Inc. $1,590 1 payment
  6. Medivation Inc. $1,350 2 payments
  7. Incyte Corporation $450 2 payments
  8. Novo Nordisk Inc $53 3 payments
  9. Siemens Medical Solutions USA, Inc. $41 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $451,264 356 payments
  2. Food and Beverage $94 5 payments
Products named General payments · program years 2019–2024
  1. KEYTRUDA $235,736 301 payments
  2. IMFINZI $193,125 24 payments
  3. OFEV $3,693 7 payments
  4. TALZENNA $2,940 3 payments
  5. PADCEV $2,180 2 payments
  6. MAGNETOM Vida 3T $41 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. E.R. Squibb & Sons, L.L.C. $1,501,489 61 payments
  2. Eli Lilly and Company $22,923 1 payment
  3. MorphoSys AG $5,133 12 payments
  4. AbbVie, Inc. $4,735 7 payments
  5. Pharmacyclics LLC, An AbbVie Company $1,950 1 payment
  6. BeiGene, Ltd. $1,600 1 payment
  7. Amgen Inc. $1,255 1 payment
  8. Takeda Pharmaceuticals U.S.A., Inc. $350 1 payment
  9. Janssen Research & Development, LLC $255 2 payments

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$6,524

Medicare's payments for the services billed

Medicare patients

177

Average age 79

Services billed

270

99 women, 78 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 72%
Ischemic heart disease 55%
Heart failure 46%
Chronic kidney disease 46%
Depression 45%
Diabetes 44%
Atrial fibrillation 44%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

448 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record